As of Feb 24
| -0.03 / -2.44%|
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 7.53, with a high estimate of 7.53 and a low estimate of 7.53. The median estimate represents a +527.79% increase from the last price of 1.20.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.